Yaron Werber
Stock Analyst at TD Cowen
(1.07)
# 3,666
Out of 4,931 analysts
37
Total ratings
34.62%
Success rate
-12.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines | Reiterates: Buy | $334 | $298.52 | +11.89% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $10.58 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $20.39 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $11.75 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $182.60 | -16.21% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $111.30 | +9.61% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $16.72 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $28.05 | +160.25% | 2 | Oct 21, 2024 | |
| EXEL Exelixis | Maintains: Buy | $27 → $34 | $37.71 | -9.84% | 2 | Oct 21, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $54 → $59 | $40.69 | +45.00% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $37.66 | +77.91% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $13.17 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.90 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.52 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.44 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $673.15 | -4.78% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.28 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $7.11 | +8,696.62% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.31 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $21.51 | +76.66% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.96 | - | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.65 | - | 1 | Oct 26, 2021 |
BeOne Medicines
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $298.52
Upside: +11.89%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $10.58
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $20.39
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $11.75
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $182.60
Upside: -16.21%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $111.30
Upside: +9.61%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $16.72
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $28.05
Upside: +160.25%
Exelixis
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $37.71
Upside: -9.84%
Ionis Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $40.69
Upside: +45.00%
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $37.66
Upside: +77.91%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $13.17
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.90
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $3.52
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $21.44
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $673.15
Upside: -4.78%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.28
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $7.11
Upside: +8,696.62%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $26.31
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $21.51
Upside: +76.66%
Nov 30, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.96
Upside: -
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.65
Upside: -